* Phibro Animal Health Corp PAHC.OQ PAHC.O is expected
to show
a rise in quarterly revenue when it reports results on May 3.
* The Teaneck New Jersey-based company is expected to
report a
3.3% increase in revenue to $247.463 million from $239.62
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Phibro Animal
Health Corp
is for earnings of 34 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Phibro
Animal
Health Corp is $18, above its last closing price of $15.87.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 0.30 0.30 0.34 Beat 12.2
Sep. 30 2022 0.27 0.27 0.21 Missed -20.9
Jun. 30 2022 0.38 0.38 0.26 Missed -32.1
Mar. 31 2022 0.35 0.35 0.33 Missed -6.6
Dec. 0.32 0.33 0.37 Beat 13.3
31 2021
Sep. 30 2021 0.27 0.29 0.25 Missed -14.8
Jun. 30 2021 0.32 0.31 0.32 Beat 2.5
Mar. 31 2021 0.32 0.34 0.34 Met 1.3
This summary was machine generated May 2 at 02:01 GMT. All
figures in US dollars unless otherwise stated